Episode Details
Back to Episodes
EP228: Covid-19 and Arrythmia
Description
Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.
Podcast Summary
Dr. Warrick Bishop is a practicing cardiologist who hosts educational podcasts aimed at helping patients understand their heart health. In this episode, Dr. Bishop addresses common questions from patients regarding COVID-19 and its specific implications for those with arrhythmias and other cardiac conditions. The episode focuses on clarifying misconceptions and providing practical guidance for cardiac patients during the pandemic.
Key Takeaways:
-
Patients with well-controlled arrhythmias and no other comorbidities are not necessarily at increased risk from COVID-19, as the virus primarily affects those with diminished immunity.
-
Atrial fibrillation in isolation does not significantly increase COVID-19 risk, but when combined with other conditions like hypertension, diabetes, or heart failure, it becomes a marker for higher risk.
-
Ventricular arrhythmias (rhythms from the heart's lower chambers) are more concerning as they typically indicate underlying heart dysfunction and carry increased risk for poor COVID-19 outcomes.
-
Pacemaker patients are not inherently at higher risk from COVID-19 and should utilize remote monitoring options when available to avoid hospital exposure.
-
Patients with defibrillators or cardiac resynchronization devices have compromised left ventricular function and should exercise particular caution due to elevated COVID-19 risk.
-
Current evidence does not support discontinuing ACE inhibitor or angiotensin II blocker medications due to COVID-19 fears, despite theoretical concerns about lung receptor interactions.
-
The hypertension rate observed in severe COVID-19 cases matches the baseline hypertension rate in general populations, suggesting no specific increased risk.
-
The virus can survive up to 72 hours on hard surfaces, 24 hours on soft surfaces, and several hours in the air, making proper hygiene and handwashing essential preventive measures.
-
Soap and alcohol-based products effectively combat the virus due to its lipid coating, as do bleach and peroxide solutions.